Chinese giant-hyssop

Agastache rugosa

Also known as: Chinese giant-hyssop(English)

Updated October 5, 2026 · Not yet clinically reviewed

Chinese giant-hyssop

Safety at a glance

Note

4 recorded drug interactions

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Western herbalism

Properties: carminative, antimicrobial, antispasmodic

Formulas using this herb

18 of 18 formulas

Botanical

Agastache rugosa, the Korean mint or Chinese giant hyssop, is an erect aromatic perennial herb of the mint family native to East Asia, growing roughly fifty centimetres to one and a half metres tall. The square, branching stems bear opposite, ovate to lance-shaped leaves with coarsely toothed margins, pointed tips, and a wrinkled (rugose) upper surface; when crushed the foliage releases a strong anise- or licorice-scented aroma. The small two-lipped flowers are densely crowded into cylindrical terminal spikes several centimetres long; they range from pale purple and violet to occasionally white, each with a tubular calyx and protruding stamens, and are highly attractive to bees and other pollinators. Flowering occurs through summer into autumn, followed by small dry nutlets. Widely distributed in China, Korea, Japan, and the Russian Far East, it grows on hillsides, roadsides, and forest margins and is also cultivated as a culinary herb and ornamental.

Family
Lamiaceae
Parts used
whole_plant, leaf
Plant type
herb
Native region
Amur, China North-Central, Japan, Khabarovsk, Korea, Kuril Is., Manchuria, Primorye, Taiwan

Constituents

Estragole (methyl chavicol)

Phenylpropanoid (allylbenzene) · Strongly chemotype-dependent: 89.5 percent of the aerial-part essential oil in Korean-grown material, but only about 8.6 percent in Xinjiang-grown flower and leaf oil

The dominant volatile of most Korean and Japanese Agastache rugosa, and the reason the crude drug smells of anise rather than of the patchouli-alcohol note of true Guang Huo Xiang. Estragole is bioactivated by cytochrome P450 to 1'-hydroxyestragole and then sulfonated to a DNA-reactive ester; it is a rodent hepatocarcinogen, and its presence in herbal medicinal products is an active European regulatory concern rather than a settled safety question.

Methyleugenol

Phenylpropanoid (allylbenzene) · Up to about 50.5 percent of the essential oil in Xinjiang-grown flower and leaf material

In some Chinese chemotypes methyleugenol, not estragole, is the principal volatile. It shares estragole's bioactivation route to a genotoxic sulfooxy ester and is classified as a rodent carcinogen, so a methyleugenol-rich batch carries the same exposure concern as an estragole-rich one.

Pulegone

Monoterpene ketone · About 1.9 to 2.6 percent of the essential oil

A minor but toxicologically notable volatile. Pulegone is the hepatotoxic principle of pennyroyal oil, depleting glutathione through its menthofuran metabolite; at the low percentages found in Agastache rugosa oil it is unlikely to matter in decoction, but it argues against using the concentrated essential oil internally.

D-Limonene

Monoterpene hydrocarbon · About 2.5 to 3.4 percent of the essential oil

Contributes the light citrus top note of the fresh herb and has mild carminative and antimicrobial activity in vitro.

Tilianin (acacetin 7-O-beta-D-glucopyranoside)

Flavone glycoside · Principal non-volatile flavonoid of the aerial part; used with acacetin as an HPLC quality marker

The main flavone glycoside of the aerial part and one of the compounds routinely quantified for quality control. In cell models it suppresses adipogenesis and lipogenesis, and it is the glycosidic reservoir that supplies acacetin after intestinal hydrolysis.

Acacetin

Flavone aglycone · Present in the aerial part and generated from tilianin by hydrolysis

A potent xanthine oxidase inhibitor in vitro, making it the constituent behind the herb's measured urate-lowering activity in enzyme assays. It also contributes to the anti-inflammatory profile of the aerial part.

Rosmarinic acid

Caffeic acid ester (phenolic acid) · Major water-soluble phenolic of the aerial part; accumulation is developmentally regulated

The dominant polar antioxidant of the herb and the constituent most likely to survive into a water decoction. It scavenges reactive oxygen species and inhibits pro-inflammatory signalling in cell models.

Agastachoside

Flavone glycoside · Minor constituent of the aerial part

One of the genus-characteristic flavone glycosides of Agastache rugosa, reported alongside tilianin and linarin. It is chiefly of chemotaxonomic value; no distinct pharmacology has been established for it.

Drug interactions

Pogostemon cablin (Guang Huo Xiang)

Moderate · Substitution error rather than a pharmacological interaction, but it changes what the patient actually receives · Evidence level: Established

Agastache rugosa is Tu Huo Xiang, the country or native Huo Xiang; only Pogostemon cablin is accepted as Guang Huo Xiang in the Chinese Pharmacopoeia, and the two are routinely traded under the shared name Huo Xiang. They are chemically unrelated: Pogostemon cablin oil is dominated by patchouli alcohol and pogostone, Agastache rugosa oil by estragole or methyleugenol. The confusion is real enough that real-time PCR DNA markers and near-infrared spectroscopic models have been developed specifically to tell the two apart in the trade.

Clinical note: Confirm which drug you have before dispensing. A prescription written for Guang Huo Xiang, or a study conducted on Pogostemon cablin, should not be filled or interpreted with Agastache rugosa, and vice versa; the aromatic damp-transforming action attributed to Guang Huo Xiang in the classical texts belongs to the Pogostemon drug.

Ketoconazole and other azole antifungals

Minor · Additive antifungal effect; no toxicity reported · Evidence level: Possible

Agastache rugosa essential oil showed synergism with ketoconazole against Candida and dermatophyte strains in checkerboard testing, lowering the azole concentration needed for inhibition. This is an in vitro observation on the essential oil, not on a decoction, and has not been reproduced in patients.

Clinical note: No dose change is warranted on this evidence. Worth knowing if a patient is using an Agastache-containing topical alongside an azole cream, where the effect would if anything be helpful.

Allopurinol and febuxostat

Theoretical · Possible additive urate lowering · Evidence level: Theoretical

Acacetin and related constituents of Agastache rugosa are potent xanthine oxidase inhibitors in cell-free enzyme assays, the same target as allopurinol and febuxostat. Whether enough acacetin reaches the enzyme after oral dosing of the crude herb has not been measured, so this remains an extrapolation from in vitro potency.

Clinical note: No action needed for ordinary culinary or decoction use. If a gout patient on urate-lowering therapy takes concentrated Agastache extract, check serum urate rather than assuming either an additive effect or none.

Fennel, star anise, basil and other estragole-rich or methyleugenol-rich herbal products

Theoretical · Cumulative genotoxic exposure, not an acute interaction · Evidence level: Probable

Estragole and methyleugenol are both bioactivated to DNA-reactive sulfooxy esters and both are rodent hepatocarcinogens; regulatory exposure assessments treat them as a combined burden across all sources rather than product by product. Agastache rugosa aerial part can be a very concentrated source, with estragole reported at nearly 90 percent of its essential oil.

Clinical note: Avoid prolonged high-dose use of the concentrated essential oil, and avoid stacking it with fennel-seed teas, star anise preparations and basil oil in the same regimen. Short courses of the decocted herb in a formula are the ordinary use and are not the concern here.

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
3
Other / unclassified
1

Potent Xanthine Oxidase Inhibitory Activity of Constituents of Agastache rugosa (Fisch. and C.A.Mey.) Kuntze

Yuk HJ, Ryu HW, Kim DS · Foods · 2023 · in vitro

In vitro / animal · Not yet verified

Constituents isolated from the aerial part were screened against xanthine oxidase, the target of allopurinol. Several flavones, acacetin foremost, inhibited the enzyme potently in the cell-free assay. The work identifies a plausible mechanism for anti-hyperuricaemic use but says nothing about serum urate in an animal or a person.

doi:10.3390/foods12030573

Potent xanthine oxidase inhibitory activity of acacetin from Agastache rugosa (Fisch. & C.A.Mey.) Kuntze in vitro and molecular docking studies

Yuk HJ, Sung YY, Kim DS · Phytochemistry Letters · 2025 · in vitro

In vitro / animal · Not yet verified

A follow-up that isolates acacetin as the principal xanthine oxidase inhibitor in the herb and models its binding to the enzyme. It confirms the earlier screening result at the level of a single compound and remains entirely preclinical.

doi:10.1016/j.phytol.2025.103994

Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazole

Shin S, Kang CA · Letters in Applied Microbiology · 2003 · in vitro

In vitro / animal · Not yet verified

The essential oil inhibited a panel of yeasts and dermatophytes and acted synergistically with ketoconazole in checkerboard assays, reducing the azole concentration required. The result concerns the volatile oil, not the decocted herb, and has no clinical follow-up.

doi:10.1046/j.1472-765x.2003.01271.x

Changes in Human Electroencephalographic Activity in Response to Agastache rugosa Essential Oil Exposure

Hong M, Jang H, Bo S, Kim M, Deepa P, Park J, Sowndhararajan K, Kim S · Behavioral Sciences · 2022 · human experimental study, single-group pre-test and post-test

Other / unclassified · Not yet verified

Thirty-eight healthy volunteers aged 20 to 30 were recorded on 29-channel EEG for 60 seconds of odourless air and then 60 seconds of air carrying Agastache rugosa essential oil. Absolute and relative theta power fell while relative alpha, relative slow alpha and spectral edge frequency indices rose, which the authors read as a shift toward an alert, freshened state. The essential oil used was 89.49 percent estragole. This is the only human data located for the species, and its weaknesses are substantial: no placebo odour, no randomisation, one very short exposure, and outcomes that are electrophysiological rather than clinical.

doi:10.3390/bs12070238

Cultural and historical

Ming Yi Bie Lu (Miscellaneous Records of Famous Physicians) · Southern and Northern Dynasties, around 500 CE

Earliest materia medica entry for Huo Xiang, described as slightly warm, treating wind-water toxic swelling, dispelling foul qi and stopping sudden turmoil disorder with heart pain. The drug intended here, and in the later Jia You Ben Cao, Ben Cao Tu Jing and Ben Cao Gang Mu, is the imported Guang Huo Xiang of Pogostemon cablin, not this species.

Dian Nan Ben Cao (Southern Yunnan Materia Medica), attributed to Lan Mao · Ming dynasty

First materia medica to enter Tu Huo Xiang as a drug name in its own right, explicitly set against the imported Guang Huo Xiang. This is the entry under which Agastache rugosa, a native Chinese and Korean plant, becomes a recorded medicine rather than a substitute.

Ben Cao Cheng Ya Ban Jie · Late Ming to early Qing, 1647

Earliest text in which content relating to the native Tu Huo Xiang plant appears, preceding its formal adoption as a separate drug name.

Pharmacopoeia of the People's Republic of China · 1977 to present

Since the 1977 edition only Pogostemon cablin has been listed, as Guang Huo Xiang; Agastache rugosa has no monograph and is not the official source of Huo Xiang. It remains in wide regional and Korean use as Tu Huo Xiang and has a United States Pharmacopeia dietary-supplement monograph for the aerial-part dry extract.

References

  1. Lin E, Zhang N, Wang Y, Liang J, Li H, Chen L. Chemical constituents, health benefits, and applications of Agastache rugosa : A review. Food Science and Human Wellness. 2025 doi:10.26599/fshw.2025.9250857
  2. Uh YR, Jang CS. Establishing DNA markers to differentiate Agastache rugosa and Pogostemon cablin, which are confusedly used as medicinal herbs, using real-time PCR. Food Science and Biotechnology. 2022 doi:10.1007/s10068-022-01176-y
  3. Lan S, Cai J, Zhao H, Wang D, Ji S. Near infrared spectroscopy discrimination and pattern recognition of Chinese Pogostemon cablin and Agastache rugosa. Journal of Holistic Integrative Pharmacy. 2023 doi:10.1016/j.jhip.2023.09.005
  4. Jerng UM, Oh YT, Kim JH. Review of Experimental Researches on Gastrointestinal Activity of Agastache rugosa (Fisch. & C. A. Mey.) Kuntze and Pogostemon cablin (Blanco) Benth. Journal of Physiology & Pathology in Korean Medicine. 2017 doi:10.15188/kjopp.2017.04.31.2.138
  5. Liu C, Li D, Dang J, Shu J, Smit SJ, Wu Q, Lichman BR. Haplotype-resolved genome of Agastache rugosa (Huo Xiang) provides insight into monoterpenoid biosynthesis and gene cluster evolution. Horticulture Research. 2025 doi:10.1093/hr/uhaf034
  6. Li H, Liu Q, Liu Z, Du S, Deng Z. Chemical Composition and Nematicidal Activity of Essential Oil of Agastache rugosa against Meloidogyne incognita. Molecules. 2013 doi:10.3390/molecules18044170
  7. Wei J, Cao P, Wang J, Kang W. Analysis of tilianin and acacetin in Agastache rugosa by high-performance liquid chromatography with ionic liquids-ultrasound based extraction. Chemistry Central Journal. 2016 doi:10.1186/s13065-016-0223-7
  8. Sievers H. Estragole in Herbal Medicinal Products – time for action?. Zeitschrift für Phytotherapie. 2023 doi:10.1055/s-0043-1769559
  9. United States Pharmacopeial Convention. Agastache rugosa Aerial Parts Dry Extract. USP-NF doi:10.31003/uspnf_m18635_010101_01
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice